Stereochemistry | ACHIRAL |
Molecular Formula | C8H14N4O2 |
Molecular Weight | 198.2224 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1[C@H]2[C@H](N(C)C(=O)N2C)N(C)C1=O
InChI
InChIKey=XIUUSFJTJXFNGH-OLQVQODUSA-N
InChI=1S/C8H14N4O2/c1-9-5-6(11(3)7(9)13)12(4)8(14)10(5)2/h5-6H,1-4H3/t5-,6+
Molecular Formula | C8H14N4O2 |
Molecular Weight | 198.2224 |
Charge | 0 |
Count |
MOL RATIO
1 MOL RATIO (average) |
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Tetramethylglycoluril (MEBICAR, Adaptol, Mebicarum) is an anxiolytic similar to organism natural metabolites with nootropic and stress-protective characteristics. Tetramethylglycoluril belongs to a group of non-benzodizepam tranquilizers. It works by effecting on the structure of limbic-reticular activity and 4 main neuromediator systems – γ aminobutyric acid, choline -, serotonin- and adrenergic. Tetramethylglycoluril increases serotonin levels, decreases noradrenaline level with no effect on dopamine and no anticholinergic activity. It acts on hypothalamus emotional zone, thus providing moderate tranquilizing effect. Tetramethylglycoluril improves oxygen consumption by myocardium, normalizes blood electrolyte balance, stimulates protein synthesis and increases cell's energy resource. Tetramethylglycoluril is used to treat neurotic disorders (anxiety, awareness, fear, emotional density, irritability) caused by exhausting psycho-emotional, nervous and physical loads. Mebicar relieves or completely removes nicotine abstinence.
Originator
Approval Year
PubMed
Patents
Sample Use Guides
500 mg 2-3 times a day. The maximum single dose is 3 g, the daily - 10 g. The duration of the course of treatment is from several days to 2-3 months.
In complex therapy as a means of reducing the craving for tobacco smoking - 500-1000 mg 3 times a day for 5-6 weeks.
Route of Administration:
Oral